XML 73 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Joint Venture and Equity Method Investment - Narrative (Details)
$ in Thousands, shares in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 04, 2022
USD ($)
Mar. 29, 2022
USD ($)
Jul. 31, 2018
USD ($)
Apr. 30, 2021
USD ($)
Feb. 28, 2021
USD ($)
day
Jul. 31, 2022
USD ($)
Jul. 31, 2021
USD ($)
Jul. 31, 2022
USD ($)
shares
Jul. 31, 2021
USD ($)
Jan. 31, 2022
USD ($)
Noncontrolling Interest [Line Items]                    
Stock-based compensation expense           $ 37,747 $ 5,232 $ 55,218 $ 8,663  
Contributions received from noncontrolling interests, net of issuance costs               57,673 26,450  
Decrease in net assets upon consolidation $ 9,400                  
Decrease from deconsolidation               11,342    
Carrying value of investment           14,581 [1]   14,581 [1]   $ 0
Loss from equity method investment, net of tax           (816) $ 0 (1,019) $ 0  
Shares subject to the 2021 ESPP | 2021 Employee Stock Purchase Plan                    
Noncontrolling Interest [Line Items]                    
Compensation expense not yet recognized           31,700   $ 31,700    
Period for recognition (in years)               1 year 9 months 18 days    
Meltano Inc.                    
Noncontrolling Interest [Line Items]                    
Equity method investment, cost 17,800                  
Stake in equity method investment (as a percent)               98.00%    
Noncontrolling Interests                    
Noncontrolling Interest [Line Items]                    
Stock-based compensation expense           2,755   $ 2,972    
Decrease from deconsolidation 11,300             11,342    
Accumulated Deficit                    
Noncontrolling Interest [Line Items]                    
Decrease from deconsolidation 15,900                  
JiHu                    
Noncontrolling Interest [Line Items]                    
Consideration received on transaction, net of discounts   $ 27,700                
Net of issuance costs           22,800   22,800    
Stock-based compensation expense           2,800   3,000    
Compensation expense not yet recognized           $ 20,600   $ 20,600    
Period for recognition (in years)               3 years 8 months 12 days    
Meltano Inc.                    
Noncontrolling Interest [Line Items]                    
Consideration received on transaction, net of discounts $ 7,200                  
Contributions received from noncontrolling interests, net of issuance costs       $ 4,200            
Meltano Inc. | Employee stock options                    
Noncontrolling Interest [Line Items]                    
Potentially dilutive equity instruments (in shares) | shares               2.6    
Meltano Inc. | Preferred Stock                    
Noncontrolling Interest [Line Items]                    
Stake in equity method investment (as a percent)               50.00%    
Potentially dilutive equity instruments (in shares) | shares               3.1    
JiHu                    
Noncontrolling Interest [Line Items]                    
Ownership percentage by noncontrolling owners   72.00%                
Ownership percentage   56.00%                
Meltano Inc.                    
Noncontrolling Interest [Line Items]                    
Ownership percentage by noncontrolling owners       12.00%            
Investment in subsidiary     $ 400              
Variable Interest Entity, Primary Beneficiary | JiHu                    
Noncontrolling Interest [Line Items]                    
Loans payable         $ 2,900          
Loan payable, period (in days) | day         10          
[1] (1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.